MoneyWorks4Me

Abbott India informs about related party transactions

25 Jun 2019 Evaluate

Pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Abbott India has informed about disclosure of related party transactions on a consolidated basis, in the format specified in the accounting standards for the year ended March 31, 2019. The above disclosure is also available on the website of the Company i.e. www.abbott.co.in.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..